
P3 Health Partners Inc.
P3 Health Partners Inc. (PIII) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PIII · as of Jun 9, 2026
Key Statistics
Explore P3 Health Partners Inc. Data
piii stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 50.0%
The PIII analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $9.00, representing -26.53% downside from the current price of $12.25.
Competitors & Peers
piii competitorsStock Performance
Full HistoryAbout P3 Health Partners Inc.
P3 Health Partners Inc. is a population health management enterprise that delivers exceptional, patient-centered care throughout the United States. Guided by physician leadership, this company manages…
what is p3 health partners inc. · piii stock overview · p3 health partners inc. company profile · who is p3 health partners inc. ceo · piii NASDAQ · p3 health partners inc. headquarters · p3 health partners inc. business segments
About Stock Overview & Key Data
P3 Health Partners Inc. (PIII) is a Healthcare company in the Medical - Care Facilities industry, listed on NASDAQ since Apr 6, 2021. As of the latest trading session, PIII stock price is $12.25, with a market capitalization of $40.4M. The stock has returned +86.74% over the past 12 months and +251.00% year-to-date.
According to 4 Wall Street analysts, the consensus rating for P3 Health Partners Inc. stock is Buy, with an average 12-month price target of $9.00. In fiscal year 2025, P3 Health Partners Inc. reported revenue of $1.5B and net income of -$147.9M. For detailed data — including P3 Health Partners Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, P3 Health Partners Inc. (PIII) stock price is $12.25. The stock is traded on NASDAQ under the ticker symbol PIII. The 52-week range is $1.52 – $16.89.